Covenant Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Covenant Asset Management's IDXX Position: Q2 2024 in Review
Covenant Asset Management sold out of Idexx Laboratories (IDXX) in Q2 2024, closing a stake of 6,484 shares — an estimated $3.5M sold.
Covenant Asset Management first reported a position in IDXX in Q1 2019 and held it in 21 quarters. The position peaked at $4.79M in Q4 2021. 1,109 funds tracked by Wall St. Rank hold IDXX as of Q2 2024.
- Covenant Asset Management reported no remaining Idexx Laboratories position as of Q2 2024 after selling out during the quarter.
- Covenant Asset Management sold 6,484 Idexx Laboratories shares in Q2 2024, an estimated $3.5M.
- Covenant Asset Management first reported a position in Idexx Laboratories in Q1 2019 and held it in 21 quarters.
- Covenant Asset Management's Idexx Laboratories position peaked at $4.79M in Q4 2021.
- 1,109 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2024.
Based on Covenant Asset Management's 13F filing for Q2 2024, filed 2 Aug 2024.